Co-Diagnostics (NASDAQ:CODX) inks an agreement with Madison, WI-based Promega for additional manufacturing capacity for its Logix Smart COVID-19 test.
Promega has the capability to produce product in high volumes and can start immediately.
The company says its test is currently available to all CLIA-certified labs.
https://seekingalpha.com/news/3560385-co-diagnostics-up-7-premarket-on-expanded-manufacturing-capacity-for-covidminus-19-test
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.